|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ,
Lee JY, Ryu KW, Nam BH, Kook MC and Kim YW: Long-term outcome
comparison of endoscopic resection and surgery in early gastric
cancer meeting the absolute indication for endoscopic resection.
Gastrointest Endosc. 81:333–341 e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fukagawa T, Katai H, Mizusawa J, Nakamura
K, Sano T, Terashima M, Ito S, Yoshikawa T, Fukushima N, Kawachi Y,
et al: A prospective multi-institutional validity study to evaluate
the accuracy of clinical diagnosis of pathological stage III
gastric cancer (JCOG1302A). Gastric Cancer. 21:68–73. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smyth EC, Verheij M, Allum W, Cunningham
D, Cervantes A and Arnold D; ESMO Guidelines Committee, : Gastric
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 27 (Suppl 5):v38–v49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valinezhad Orang A, Safaralizadeh R and
Kazemzadeh-Bavili M: Mechanisms of miRNA-mediated gene regulation
from common downregulation to mRNA-specific upregulation. Int J
Genomics. 2014:9706072014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan HL, Wang T and Zhang KH: MicroRNAs as
potential biomarkers for diagnosis, therapy and prognosis of
gastric cancer. Onco Targets Ther. 11:3891–3900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dehghanzadeh R, Jadidi-Niaragh F, Gharibi
T and Yousefi M: MicroRNA-induced drug resistance in gastric
cancer. Biomed Pharmacother. 74:191–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li GF, Li L, Yao ZQ and Zhuang SJ:
Hsa_circ_ 0007534/miR-761/ZIC5 regulatory loop modulates the
proliferation and migration of glioma cells. Biochem Biophys Res
Commun. 499:765–771. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao S, Lin L, Xia X and Wu H: MicroRNA-761
promotes the sensitivity of colorectal cancer cells to
5-Fluorouracil through targeting FOXM1. Oncotarget. 9:321–331.
2017.PubMed/NCBI
|
|
11
|
Guo GC, Wang JX, Han ML, Zhang LP and Li
L: microRNA-761 induces aggressive phenotypes in triple-negative
breast cancer cells by repressing TRIM29 expression. Cell Oncol
(Dordr). 40:157–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou X, Zhang L, Zheng B, Yan Y, Zhang Y,
Xie H, Zhou L, Zheng S and Wang W: MicroRNA-761 is upregulated in
hepatocellular carcinoma and regulates tumorigenesis by targeting
Mitofusin-2. Cancer Sci. 107:424–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi C and Zhang Z: miR-761 inhibits tumor
progression by targeting MSI1 in ovarian carcinoma. Tumour Biol.
37:5437–5443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan A, Yang C, Chen Z, Li C and Cai L:
MiR-761 promotes progression and metastasis of non-small cell lung
cancer by targeting ING4 and TIMP2. Cell Physiol Biochem. 37:55–66.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng ZH, Fang Y, Zhao LY, Lu J, Wang YQ,
Chen ZH, Huang Y, Wei JH, Liang YP, Cen JJ, et al: RIN1 promotes
renal cell carcinoma malignancy by activating EGFR signaling
through Rab25. Cancer Sci. 108:1620–1627. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li F, Fang Z, Zhang J, Li C, Liu H, Xia J,
Zhu H, Guo C, Qin Z, Li F, et al: Identification of TRA2B-DNAH5
fusion as a novel oncogenic driver in human lung squamous cell
carcinoma. Cell Res. 26:1149–1164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu HY, Wu G, He H, Wang YW, Cheng Y and
Liu YF: RIN1 expression in hepatocellular cancer and the affection
on prognosis and tumor invasion ability. Zhonghua Wai Ke Za Zhi.
51:1025–1029. 2013.(In Chinese). PubMed/NCBI
|
|
19
|
Fang P, Zhao Z, Tian H and Zhang X: RIN1
exhibits oncogenic property to suppress apoptosis and its aberrant
accumulation associates with poor prognosis in melanoma. Tumour
Biol. 33:1511–1518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu HF, Zhao G, Ge ZJ, Wang DR, Chen J,
Zhang Y, Zha TZ, Zhang K, Zhang M, Tan YF, et al: High RIN1
expression is associated with poor prognosis in patients with
gastric adenocarcinoma. Tumour Biol. 33:1557–1563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shan GY, Zhang Z, Chen QG, Yu XY, Liu GB
and Kong CZ: Overexpression of RIN1 associates with tumor grade and
progression in patients of bladder urothelial carcinoma. Tumour
Biol. 33:847–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Q, Gao Y, Tang Y, Ma L, Zhao M and
Wang X: Prognostic significance of RIN1 gene expression in human
non-small cell lung cancer. Acta Histochem. 114:463–468. 2012.
View Article : Google Scholar : PubMed/NCBI
|
